Precision Optics Corporation (POCI) Liabilities and Shareholders Equity (2011 - 2026)
Precision Optics Corporation (POCI) reported Liabilities and Shareholders Equity of $33.7 million for Q1 2026, up 71.67% year-over-year from $19.6 million in Q1 2025, and up 47.13% quarter-over-quarter from $22.9 million in Q4 2025.
Precision Optics Corporation (POCI) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
Precision Optics Corporation (POCI) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $33.7 million in Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $33.7 million, up 71.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $98.8 million (up 38.54% YoY), and the FY2025 annual result was $19.8 million, up 17.02% from the prior year.
- Liabilities and Shareholders Equity climbed to $33.7 million in Q1 2026 per POCI's latest filing, from $22.9 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $33.7 million in Q1 2026 and troughed at $16.7 million in Q2 2022.
- A 5-year average of $19.5 million and a median of $18.2 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity jumped 192.37% in 2022, then dropped 14.33% in 2024.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $17.5 million in 2022, then gained by 1.31% to $17.7 million in 2023, then declined by 1.06% to $17.5 million in 2024, then surged by 30.75% to $22.9 million in 2025, then jumped by 47.13% to $33.7 million in 2026.
- Business Quant data shows POCI's Liabilities and Shareholders Equity at $33.7 million in Q1 2026, $22.9 million in Q4 2025, and $22.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 20.11 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 50.83 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 39.01 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 8.78 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.11 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 14.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 6.31 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 19.85 Bn |
| 10 | Precision Optics Corporation | 44.43 Mn | 33.75 Mn | 2.06 Mn | 33.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.69 Mn |
| Dec 31, 2025 | 22.90 Mn |
| Sep 30, 2025 | 22.38 Mn |
| Jun 30, 2025 | 19.79 Mn |
| Mar 31, 2025 | 19.62 Mn |
| Dec 31, 2024 | 17.51 Mn |
| Sep 30, 2024 | 17.24 Mn |
| Jun 30, 2024 | 16.91 Mn |
| Mar 31, 2024 | 18.27 Mn |
| Dec 31, 2023 | 17.70 Mn |
| Sep 30, 2023 | 19.07 Mn |
| Jun 30, 2023 | 19.74 Mn |
| Mar 31, 2023 | 18.19 Mn |
| Dec 31, 2022 | 17.47 Mn |
| Sep 30, 2022 | 17.17 Mn |
| Jun 30, 2022 | 16.70 Mn |
| Mar 31, 2022 | 17.27 Mn |
| Dec 31, 2021 | 16.89 Mn |
| Sep 30, 2021 | 7.10 Mn |
| Jun 30, 2021 | 6.26 Mn |